Eligibility Requirements

• Must be a U.S. based non-profit organization with services for people living with Duchenne muscular dystrophy

• Must hold current 501(c)(3) status

Application Requirements

• Applications must be concise and approximately three (3) pages in length. Font size ≥ 10

• Statement of target demographic and identified community need(s)

• A detailed description of the project plan and timeline for implementation

• A goal that is clearly outlined, measurable, and attainable

• A project budget detailing how proceeds of the grant will be allocated

• A commitment to apply grant funding within one-year of receipt and to provide Entrada with a project summary

Only one application per non-profit organization will be considered. A written agreement, defining the basic conditions of the grant, will be entered between Entrada Therapeutics and the award recipients.

Review Criteria

Applications will be judged by an independent review committee comprised of neuromuscular specialists and patient advocates with expertise in Duchenne, Diversity, Equity, Inclusion & Access (DEIA), social impact and health. Each application will be anonymized and reviewed, scored, and ranked using the following criteria:

Inclusivity

• Accessible to intended audience (e.g., multilingual, ADA compliant, culturally relevant, etc.)

• Informed by minority-led or representative community organization(s)

Reach

• Delivers to underserved community(s) where they are

• Reproducible in multiple geographies

• Addresses needs of multiple underserved groups

Vision

• Addresses a clear unmet need

• Specific objective and measure of success

• Sustainable

Uniqueness

• Novel idea or program

• Shows commitment to a new way of working to advance DEIA

In addition to meeting the criteria above, applicants are encouraged to demonstrate collaboration with minority-led or local community organizations to overcome barriers that limit the delivery of health education and support for individuals and families in need.